Vaishali Pharma launches series of immunity booster products worldwide

Vaishali Pharma Limited has successfully launched its series of immunity booster products worldwide. The products range includes Vipravita C (tablets and effervescent), Vipravita CZ (tablets), Vipravita D3, Viprafolic A, Vipravita, Vipramultivita, Ascorzee (tablet), herbal cough drops, Viprasure (powder), Vipra C (Gummies), Vipra B (Gummies), Vipra M (Gummies), multi-vitamin (effervescent), Women D (effervescent). 

These products would help to improve immunity and fight against disease-causing germs like bacteria, COVID -19 viruses, parasites or fungi, etc. 

It has launched these products across countries like Sudan, Oman, Dubai, Iraq, Congo, Kenya, Sri Lanka, Philippines, Lesotho, etc. 

This has enabled the company to strengthen its presence in the high growth market and reach out to more and more territories. Last month, it had received an order worth USD 2,70,000 from Afghanistan for the supply of API, packaging material like capsule, glass vial, rubber stopper, flip-off seal, sterile water for injection, etc, and specific machinery setup such as tablets manufacturing machines. 

Vaishali Pharma is amongst the leading players in the supply of pharma products – bulk drugs/APIs, formulations, surgical products, veterinary supplements, herbal & nutraceutical products. It has over 150+ formulation brands marketed in multiple countries and also, built a robust pipeline of around 250 dossiers. 

On Monday, the stock of Vaishali Pharma opened at Rs 42.30 on NSE. At 11.28 am, it was trading 3.10 per cent up at Rs 43.20 from its previous close of Rs 41.90.